Inhibitors | Comment | Organism | Structure |
---|---|---|---|
N-(3-bromobenzyl)-1-(2-(methylamino)ethyl)piperidin-4-amine | potent and selective inhibitor of CARM1. It is around 20fold selective for CARM1 over PRMT6 and highly selective over PRMT1, PRMT3, PRMT8 as well as PRMT5 and PRMT7 | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
2 S-adenosyl-L-methionine + [CBP/p300]-L-arginine | Homo sapiens | - |
2 S-adenosyl-L-homocysteine + [CBP/p300]-Nomega,Nomega-dimethyl-L-arginine | - |
? | |
2 S-adenosyl-L-methionine + [histone H3R17]-L-arginine | Homo sapiens | - |
2 S-adenosyl-L-homocysteine + [histone H3R17]-Nomega,Nomega-dimethyl-L-arginine | - |
? | |
2 S-adenosyl-L-methionine + [histone H3R26]-L-arginine | Homo sapiens | - |
2 S-adenosyl-L-homocysteine + [histone H3R26]-Nomega,Nomega-dimethyl-L-arginine | - |
? | |
2 S-adenosyl-L-methionine + [NCOA2]-L-arginine | Homo sapiens | - |
2 S-adenosyl-L-homocysteine + [NCOA2]-Nomega,Nomega-dimethyl-L-arginine | - |
? | |
2 S-adenosyl-L-methionine + [PABP1]-L-arginine | Homo sapiens | - |
2 S-adenosyl-L-homocysteine + [PABP1]-Nomega,Nomega-dimethyl-L-arginine | - |
? | |
2 S-adenosyl-L-methionine + [SAP49]-L-arginine | Homo sapiens | - |
2 S-adenosyl-L-homocysteine + [SAP49]-Nomega,Nomega-dimethyl-L-arginine | - |
? | |
2 S-adenosyl-L-methionine + [SRC-3]-L-arginine | Homo sapiens | - |
2 S-adenosyl-L-homocysteine + [SRC-3]-Nomega,Nomega-dimethyl-L-arginine | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q86X55 | - |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
2 S-adenosyl-L-methionine + [CBP/p300]-L-arginine | - |
Homo sapiens | 2 S-adenosyl-L-homocysteine + [CBP/p300]-Nomega,Nomega-dimethyl-L-arginine | - |
? | |
2 S-adenosyl-L-methionine + [histone H3R17]-L-arginine | - |
Homo sapiens | 2 S-adenosyl-L-homocysteine + [histone H3R17]-Nomega,Nomega-dimethyl-L-arginine | - |
? | |
2 S-adenosyl-L-methionine + [histone H3R26]-L-arginine | - |
Homo sapiens | 2 S-adenosyl-L-homocysteine + [histone H3R26]-Nomega,Nomega-dimethyl-L-arginine | - |
? | |
2 S-adenosyl-L-methionine + [NCOA2]-L-arginine | - |
Homo sapiens | 2 S-adenosyl-L-homocysteine + [NCOA2]-Nomega,Nomega-dimethyl-L-arginine | - |
? | |
2 S-adenosyl-L-methionine + [PABP1]-L-arginine | - |
Homo sapiens | 2 S-adenosyl-L-homocysteine + [PABP1]-Nomega,Nomega-dimethyl-L-arginine | - |
? | |
2 S-adenosyl-L-methionine + [peptide]-L-arginine | - |
Homo sapiens | 2 S-adenosyl-L-homocysteine + [peptide]-Nomega,Nomega-dimethyl-L-arginine | - |
? | |
2 S-adenosyl-L-methionine + [SAP49]-L-arginine | - |
Homo sapiens | 2 S-adenosyl-L-homocysteine + [SAP49]-Nomega,Nomega-dimethyl-L-arginine | - |
? | |
2 S-adenosyl-L-methionine + [SRC-3]-L-arginine | - |
Homo sapiens | 2 S-adenosyl-L-homocysteine + [SRC-3]-Nomega,Nomega-dimethyl-L-arginine | - |
? |
Synonyms | Comment | Organism |
---|---|---|
CARM1 | - |
Homo sapiens |
coactivator-associated arginine methyltransferase 1 | - |
Homo sapiens |
PRMT4 | - |
Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.000094 | - |
pH and temperature not specified in the publication | Homo sapiens | N-(3-bromobenzyl)-1-(2-(methylamino)ethyl)piperidin-4-amine |
General Information | Comment | Organism |
---|---|---|
drug target | the enzme is associated with several human cancers including breast, colon, prostate and lung cancers and thus, is a potential oncological target | Homo sapiens |
physiological function | the enzyme (CARM1) functions as a coactivator for various proteins that have been linked to cancer such as p53, NF-kappabeta, beta-catenin, E2F1 and steroid hormone receptor ERalpha. CARM1 is involved in transcriptional activation, cellular differentiation, cell cycle progression, RNA splicing and DNA damage response | Homo sapiens |